Is Guided Therapeutics, Inc. (GTHP) a Buy, Sell, or Hold?
OTC : GTHP
Guided Therapeutics, Inc.
$0.27 USD
-$0.01 (-3.57%)
- Volume
- 17.5K
- Average Volume
- 12.87K
- Market Capitalization
- $20.71M
- P/E Ratio
- -6.05
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.54
- Year Low
- $0.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.02
- Current Ratio
- $0.15
| Source | Headline |
|---|---|
|
Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection ba gurufocus.com - 2026-06-16 09:02:00 |
|
Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced today it had filed the results of its multicenter clinical trial with the U.S. Food and Drug Administration (FDA). The study protocol was developed through interactions with FDA and enrolled 480 women referred to biopsy because of abnormal Pap a. businesswire.com - 2026-06-16 09:00:00 |
